Alterity Therapeutics To Present At The MST Access ‘Hidden Gems In Life Sciences’ Webinar
AUSTRALIA PARTICIPANTS: | ||
Date: | Thursday, 13 June 2024 | |
Time: | 1:30 p.m. AEST (Sydney/Melbourne) | |
UNITED STATES PARTICIPANTS: | ||
Date: | Wednesday, 12 June 2024 | |
Time: | 8:30 p.m. Pacific Time | |
11:30 p.m. Eastern Time |
To join the presentation, please click the webinar link here .
Investors will have the opportunity to ask questions during the call, at the conclusion of the presentation.
A recording of the webinar will be made available on the Alterity Therapeutics website after the event, which you can access here: .
About Alterity Therapeutics Limited
Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases. The Company's lead asset, ATH434, has the potential to treat various Parkinsonian disorders and is currently being evaluated in two Phase 2 clinical trials in Multiple System Atrophy. Alterity also has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases. The Company is based in Melbourne, Australia, and San Francisco, California, USA. For further information please visit the Company's website at .
Authorisation & Additional information
This announcement was authorized by David Stamler, CEO of Alterity Therapeutics Limited.
Investor and Media Contacts:
Australia
Hannah Howlett
...
+61 450 648 064
U.S.
Remy Bernarda
...
+1 (415) 203-6386


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Mutuum Finance (MUTM) New Crypto Coin Eyes Next Price Increase As Phase 6 Reaches 50% Sold
- Tradesta Becomes The First Perpetuals Exchange To Launch Equities On Avalanche
- Bydfi Joins Korea Blockchain Week 2025 (KBW2025): Deepening Web3 Engagement
- Over US$13 Billion Have Trusted Pendle, Becoming One Of The Largest Defi Protocols On Crypto
- Cregis Joins TOKEN2049 Singapore 2025
- Daytrading Publishes New Study Showing 70% Of Viral Finance Tiktoks Are Misleading
Comments
No comment